CAS 191732-72-6: Lenalidomide
Description:Lenalidomide is a synthetic derivative of thalidomide and is classified as an immunomodulatory drug. It is primarily used in the treatment of multiple myeloma and certain types of myelodysplastic syndromes. The chemical formula of lenalidomide is C13H13N3O3, and it features a unique structure that includes a phthalimide moiety, which contributes to its biological activity. Lenalidomide exhibits anti-inflammatory, anti-angiogenic, and anti-tumor properties, largely through modulation of the immune system and inhibition of pro-inflammatory cytokines. It is known to enhance T-cell and natural killer cell activity, promoting the body's ability to fight cancer. The drug is typically administered orally and has a relatively long half-life, allowing for convenient dosing schedules. Common side effects may include fatigue, nausea, and hematological abnormalities, necessitating regular monitoring of blood counts during treatment. Lenalidomide's mechanism of action and its efficacy in various hematological malignancies have made it a significant therapeutic agent in oncology.
Formula:C13H13N3O3
InChI:InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)
InChI key:InChIKey=GOTYRUGSSMKFNF-UHFFFAOYSA-N
SMILES:O=C1NC(=O)C(N2C(=O)C=3C=CC=C(N)C3C2)CC1
- Synonyms:
- 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
- 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-
- 3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione
- CC 5013
- Revimid